Often there are no symptoms, but some people may experience abdominal pain, nausea, or fatigue.
Hightower’s past efforts aim to manage and treat this condition effectively and have better patient outcome.
Severe hypertriglyceridemia is a condition characterized by high levels, typically at or above 500 mg/dL. This condition is concerning because it can significantly increase the risk of developing acute pancreatitis, an inflammation of the pancreas.
Hightower Clinical conducted a study to assess the effectiveness of a new drug treatment in managing triglyceride levels in individuals with severe hypertriglyceridemia. The goal was to evaluate the drug’s ability to reduce the risk of complications associated with this condition.
Not Recruiting
3
Study Name | Protocol Number | Sponsor |
---|---|---|
Severe Hypertriglyceridemia | Ionis Pharmaceuticals, Inc. | |
Ionis Pharmaceuticals, Inc. | ||
Ionis Pharmaceuticals, Inc. |
Often there are no symptoms, but some people may experience abdominal pain, nausea, or fatigue.
The main risk is pancreatitis, a dangerous inflammation of your pancreas. It can also increase your risk of heart disease.
Clinical trials test new treatments that could help lower your triglycerides more effectively or with fewer side effects than current medications.
Eligibility criteria vary, but trials often look for people with triglyceride levels above a certain threshold. Talk to your doctor to see if a trial might be right for you.